Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Selcia Limited
Selcia Limited
Activities:
Research & Development
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Media
Selcia joins Eurofins Group
Selcia, specialist provider of custom radiolabelling and integrated drug discovery services, announced it has been acquired by Eurofins Scientific, a global specialist in analytical testing and pharma discovery services
Research & Development
Selcia publishes strategy for structural simplification of natural products
The paper outlines a technique to generate synthetically tractable cyclophilin inhibitors for the treatment of hepatitis C
Ingredients
Selcia opens new dedicated 14C GMP API facility
To help the firm meet increasing demand for 14C radiolabelled compounds
Research & Development
Selcia and Cantab announce drug discovery collaboration
To develop improved antibiotics for multi-drug resistant Gram-negative bacterial infections
Ingredients
Selcia granted patent for drug discovery platform
The patent covers technology underpinning the UK-based company’s CEfrag drug screening service
Research & Development
Selcia exploits in-house IP with demerger
Forms Mitopharm and Selcia Pharma to protect IP while attracting external investment
Research & Development
Convergence Pharmaceuticals and Selcia in r&d collaboration
Aim is to identify and develop high quality candidate molecules for the treatment of chronic pain
Subscribe now